Filing Details

Accession Number:
0001209191-15-063077
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-31 13:44:31
Reporting Period:
2015-07-30
Filing Date:
2015-07-31
Accepted Time:
2015-07-31 13:44:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1446372 M Paul Silva C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp & Corp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-30 860 $83.36 19,235 No 4 M Direct
Common Stock Disposition 2015-07-30 100 $123.17 19,135 No 4 S Direct
Common Stock Disposition 2015-07-30 100 $125.54 19,035 No 4 S Direct
Common Stock Disposition 2015-07-30 300 $127.98 18,735 No 4 S Direct
Common Stock Disposition 2015-07-30 100 $131.26 18,635 No 4 S Direct
Common Stock Disposition 2015-07-30 160 $132.63 18,475 No 4 S Direct
Common Stock Disposition 2015-07-30 100 $132.97 18,375 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-07-30 860 $0.00 860 $83.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,874 2023-07-29 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 169 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $127.98 (range $127.60 to $128.51).
  3. Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. The option vests in 16 quarterly installments from 07/30/2013.